Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding

被引:38
|
作者
Khan, Abid
Silversides, Jon D.
Madden, Leigh
Greenman, John
Archibald, Stephen J.
机构
[1] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England
[2] Univ Hull, Inst Clin Biosci, Kingston Upon Hull HU6 7RX, N Humberside, England
[3] Univ Hull, Med Res Lab, Kingston Upon Hull HU6 7RX, N Humberside, England
基金
英国惠康基金;
关键词
D O I
10.1039/b614557d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The copper(II) complex of a novel rhodamine-azamacrocycle conjugate binds to the CXCR4 chemokine receptor and competes effectively against anti-CXCR4 monoclonal antibodies. The copper macrocycle unit adopts a trans-II configuration in the solid state.
引用
下载
收藏
页码:416 / 418
页数:3
相关论文
共 50 条
  • [1] CXCR4 chemokine receptor antagonists: perspectives in SCLC
    Burger, Jan A.
    Stewart, David J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 481 - 490
  • [2] Binding Optimization through Coordination Chemistry: CXCR4 Chemokine Receptor Antagonists from Ultrarigid Metal Complexes
    Khan, Abid
    Nicholson, Gary
    Greenman, John
    Madden, Leih
    McRobbie, Graeme
    Pannecouque, Christophe
    De Clercq, Erik
    Ullom, Robert
    Maples, Danny L.
    Maples, Randall D.
    Silversides, Jon D.
    Hubin, Timothy J.
    Archibald, Stephen J.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (10) : 3416 - +
  • [3] A future perspective on the development of chemokine receptor CXCR4 antagonists
    Tamamura, Hirokazu
    Tsutsumi, Hiroshi
    Nomura, Wataru
    Tanaka, Tomohiro
    Fujii, Nobutaka
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (10) : 1155 - 1166
  • [4] Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size
    Renard, Isaline
    D'huys, Thomas
    Burke, Benjamin P.
    Ajoleza, Trisha
    Cain, Amy N.
    Funwie, Neil L.
    Khan, Abid
    Maples, Danny L.
    Maples, Randall D.
    Matz, Dallas L.
    McRobbie, Graeme
    Ullom, Robert
    Prior, Timothy J.
    Linder, Douglas P.
    Van Loy, Tom
    Hubin, Timothy J.
    Schols, Dominique
    Archibald, Stephen J.
    PHARMACEUTICS, 2024, 16 (08)
  • [5] Structure-Based Development of Antagonists for Chemokine Receptor CXCR4
    Zhang, Chongqian
    Hou, Tingjun
    Feng, Zhiwei
    Li, Youyong
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2013, 9 (01) : 60 - 75
  • [6] Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents
    Tsutsumi, Hiroshi
    Tanaka, Tomohiro
    Ohashi, Nami
    Masuno, Hiroyuki
    Tamamura, Hirokazu
    Hiramatsu, Kenichi
    Araki, Takanobu
    Ueda, Satoshi
    Oishi, Shinya
    Fujii, Nobutaka
    BIOPOLYMERS, 2007, 88 (02) : 279 - 289
  • [7] Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
    Pawnikar, Shristi
    Miao, Yinglong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [8] Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
    Dekkers, Sebastian
    Caspar, Birgit
    Goulding, Joelle
    Kindon, Nicholas D.
    Kilpatrick, Laura E.
    Stoddart, Leigh A.
    Briddon, Stephen J.
    Kellam, Barrie
    Hill, Stephen J.
    Stocks, Michael J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5208 - 5222
  • [9] Solubilization of the chemokine receptor CXCR4
    Staudinger, R
    Bandres, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (01) : 153 - 156
  • [10] CXCR4: chemokine receptor extraordinaire
    Murdoch, C
    IMMUNOLOGICAL REVIEWS, 2000, 177 : 175 - 184